Concussion Market Size, Share & Trends Analysis Report By Assessment And Treatment (Diagnosis, Treatment), By End Use (Hospitals, Diagnostic Centers) By Region, And Segment Forecasts, 2025 - 2030

Concussion Market Size & Trends

The global concussion market size was estimated at USD 6.58 billion in 2024 and is expected to grow at a CAGR of 6.0% from 2025 to 2030. The increasing incidence of mild traumatic brain injuries (TBIs) is a key driver of market growth. In addition, the growing number of concussion awareness initiatives is expected to stimulate market expansion further. For instance, in September 2024, the World Health Organization (WHO) and FIFA launched the concussion awareness campaign "Suspect and Protect: No Match is Worth the Risk” to promote early recognition and proper management of concussions. Other factors driving the market include advancements in diagnostic technologies, such as portable concussion assessment tools, and the rising adoption of digital health solutions for remote monitoring and follow-up care.

The rising prevalence of mild traumatic brain injuries (TBIs) across various countries is anticipated to positively influence market growth in the years ahead. In May 2024, the CDC highlighted approximately 5,676 TBIs that were reported in the U.S. in January 2024. In addition, the CDC reported that over 69,000 TBI-related deaths occurred in the U.S. in 2021, amounting to 190 deaths per day. Data from the Cleveland Clinic, published in May 2024, indicates that over 75% of all TBIs are classified as mild. As a result, the increasing incidence of TBIs is projected to drive market expansion.

The occurrence of sports-related concussions is also rising significantly. in July 2024 article from the American Academy of Neurology, published, estimated that between 1.6 and 3.8 million sports-related concussions occur annually in the U.S. Various sports, including basketball, football, baseball, field hockey, ice hockey, lacrosse, rugby, softball, volleyball, and wrestling, are identified as common contributors to concussions. Furthermore, data from Engage First Aid in February 2024 revealed that National Football League (NFL) players face a 28% probability of sustaining a concussion during their careers. According to an article by the Athletic Media Company, also published in February 2024, the NFL reported 219 concussions during the 2023 preseason and regular season, compared to 213 in 2022. This increase in sports-related concussions has heightened demand for concussion treatment devices.

In parallel, academic and research institutions are actively developing innovative solutions for concussion diagnosis and treatment. For example, in September 2023, a student from Loughborough University introduced a handheld device named 'CONTACT,' designed to detect sports-related concussions within 10 seconds. The device emits light into the user's eyes, measuring variables such as pupil size, constriction speed, and the eye's responsiveness to light stimuli. Such technological innovations and the development of novel diagnostic tools are expected to significantly drive market growth in the forecast period.

Market Concentration & Characteristics

The market growth stage is moderate, and the pace of growth is accelerating. The market is characterized by a high degree of growth due to rising injuries during contact sports and mild traumatic brain injuries.

The market is experiencing high levels of innovation driven by advancements in diagnostic tools, wearable technology, and digital health platforms. Solutions such as mobile-based cognitive assessment tools, biomarker-based diagnostics, and AI-powered injury monitoring systems are transforming how concussions are detected, managed, and monitored. Government initiatives and grants play a key role in fostering growth in innovation. For instance, in June 2024, HealthTech Connex Inc. was awarded a USD 1 million grant from the government of Canada to enhance concussion detection and recovery through their innovative NeuroCatch Platform. This platform offers a quick, objective assessment of cognitive function using neurophysiological indicators, which is critical for diagnosing concussions effectively.

Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) play a crucial role in shaping the market. These authorities ensure diagnostic and therapeutic solutions' safety, efficacy, and reliability through stringent approval processes and compliance standards. Furthermore, policies on athlete safety and return-to-play protocols enforced by sports regulatory bodies like FIFA and the NCAA further influence market practices. Growing emphasis on regulatory frameworks surrounding patient care and concussion-related insurance coverage also creates new compliance challenges and opportunities for market participants.

The market is poised to experience robust mergers and acquisitions (M&A) activity as companies seek to expand their technological capabilities and market reach. Strategic acquisitions are becoming a key route for established players to integrate innovative startups specializing in digital health, diagnostics, or neurorehabilitation. For instance, in December 2023, Integra LifeSciences Holdings Corporation announced that it had finalized a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a subsidiary of Johnson & Johnson MedTech, for USD 275 million in cash at closing, with customary purchase price adjustments.

The availability of product substitutes poses challenges to the market as stakeholders explore alternative methods for managing head injuries. Substitutes include traditional paper-based cognitive tests and manual symptom assessments that are still used in clinical and sports settings. Moreover, advancements in imaging technologies such as functional MRIs and CT scans serve as alternative diagnostic approaches. Complementary therapies like mindfulness training and cognitive behavioral therapy (CBT) also provide non-medical interventions to support recovery.

Industry manufacturers focus on growing their presence in multiple nations. Manufacturers within the market are increasingly focused on expanding their presence across multiple regions to capitalize on global demand. North America remains a key market, driven by advanced healthcare infrastructure and regulatory support, while Europe offers growth potential through rising sports participation and awareness programs.

Assessment And Treatment Insights

The diagnosis segment dominated the market and accounted for the largest revenue share of 72.2% in 2024. The diagnosis segment is projected to experience substantial growth in the coming years, driven by advancements in diagnostic technologies and an increasing incidence of concussions. Key diagnostic tools include computed tomography (CT) scans, magnetic resonance imaging (MRI), electroencephalography (EEG), and other emerging techniques. The segment’s expansion is further supported by a rise in research initiatives focused on enhancing diagnostic accuracy. Numerous clinical trials and studies are underway to assess the effectiveness of various diagnostic methods, underscoring the industry’s commitment to improving concussion management.

Treatment is expected to emerge as the fastest-growing segment and is likely to grow at a CAGR of 6.4% over the forecast period. The treatment segment is expected to witness significant growth as industry players focus on developing and introducing innovative devices for concussion care. Collaborative efforts among companies are accelerating the delivery of advanced treatment solutions. For instance, in August 2024, eo, a sports technology firm, partnered with the Manly Warringah Sea Eagles, a professional sports club, to launch PolarCap—a groundbreaking, non-invasive cooling system for concussion management in contact sports. The portable device circulates cold fluid through a head cap to precisely reduce brain temperature elevated by exercise-induced head injuries, reflecting the industry's push toward novel, effective treatment options.

End Use Insights

The hospital segment accounted for the largest market share of 39.1% in 2024, driven by growing awareness of concussion-related risks and hospitals' commitment to delivering advanced diagnostic and treatment solutions. Many hospitals are adopting innovative approaches to enhance concussion care, supported by efforts to expand their expertise in managing these injuries. In addition, hospitals are launching initiatives aimed at improving clinical knowledge in this field. For instance, in September 2023, experts at the Ottawa Hospital introduced the Living Concussion Guidelines, providing healthcare professionals with essential tools to assist adults suffering from concussions and long-term symptoms.

The research centers segment is projected to grow at the fastest CAGR of 7.0% over the forecast period, driven by increased investments from governments and private organizations. Funding in this area facilitates establishing and expanding specialized research centers focused on advancing concussion management. These investments drive the development of new technologies, including advanced imaging techniques and biomarker-based studies, which further accelerate market growth. For instance, in September 2024, the Canadian government reinforced its commitment to concussion research and prevention by channeling funds through the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada.

Regional Insights

The concussion market in North America dominated the overall global market and accounted for 60.9% of revenue share in 2024. Growth in the region is fueled by heightened awareness of concussion risks, advancements in diagnostics and technology, regulatory reforms, rising sports participation, and increased focus on mental health. Several U.S. states have introduced legislation requiring schools to implement concussion management policies, including mandatory removal from play when a concussion is suspected.

Canada Concussion Market Trends

The concussion market in Canada held a significant share of the North American market in 2024, fueled by driven by the adoption of advanced technologies and a rise in contact sports participation, including football, basketball, soccer, and hockey. This increase has contributed to a surge in concussion cases, particularly among high school and college athletes, as reported by the Centers for Disease Control and Prevention (CDC). Furthermore, FDA approvals play a pivotal role in the U.S. market by ensuring products and treatments meet strict safety and efficacy standards, thereby fostering trust among healthcare providers and patients.

Europe Concussion Market Trends

The concussion market in Europe is experiencing significant growth. This market is driven by the increasing prevalence of sports-related injuries and rising awareness of the long-term impact of concussions. Government initiatives promoting safety protocols and concussion management significantly shape the market landscape. Adoption of advanced diagnostic tools, such as magnetic resonance imaging (MRI) and electroencephalography (EEG), further supports early detection and effective treatment.

The UK concussion market is likely to show significant growth propelled by increased awareness of concussion risks, particularly in sports like football and rugby. The government has implemented stricter safety protocols, emphasizing improved diagnosis, treatment, and prevention. Technological advancements, such as portable diagnostic devices and advanced imaging, enhance patient outcomes and drive demand for innovative solutions.

The concussion market in Germany is experiencing significant growth. Germany is witnessing strong growth in its market, benefiting from a robust healthcare infrastructure supported by numerous hospitals and medical device companies. The government’s Excellence Initiative has bolstered research and development (R&D) efforts, improved the capabilities of research institutes, and facilitated the development of advanced healthcare solutions.

Asia Pacific Concussion Market Trends

The concussion market in Asia Pacific is experiencing rapid growth due to several Asian Pacific markets expanding rapidly as regional governments prioritize concussion management through policy development. Many countries are implementing mandatory concussion training for coaches and healthcare professionals, fostering supportive research, education, and treatment environments. Investments in healthcare infrastructure across the region enhance access to quality concussion care services.

China concussion market is growing at a lucrative growth rate, and the growth is driven by substantial investments in healthcare infrastructure, particularly in neurological care and sports medicine. Establishing specialized concussion clinics and partnerships between hospitals and sports organizations further reflects this focus. Moreover, adopting the China Sports Concussion Assessment Guidelines has standardized diagnostic and treatment procedures, aligning with global best practices.

Latin America Concussion Market Trends

The concussion market in Latin America is experiencing significant growth, primarily driven by the increasing incidence of sports-related injuries, especially in football (soccer). This has heightened awareness among athletes, healthcare professionals, and sports organizations, driving demand for advanced diagnostic tools and treatments. In Brazil, concussions are also exacerbated by a high number of road traffic accidents, further contributing to market growth.

Middle East and Africa Concussion Market Trends

The concussion market in MEA is experiencing growth driven by governments and health organizations launching awareness campaigns about the effects of concussions, particularly in sports. This has led to a better understanding of the importance of proper diagnosis and management of concussions in the MEA. With an increase in youth participation in sports, there has been a corresponding rise in the incidence of concussions. Sports such as football, rugby, and basketball are particularly associated with head injuries.

Saudi Arabia concussion market is expected to grow significantly over the forecast period. With the Kingdom investing in sports infrastructure and promoting physical activities among its youth, there has been a parallel increase in awareness about sports injuries, including concussions. Events such as the Saudi Pro League’s popularity and international sporting events hosted in the country have heightened attention to athlete health and safety. For instance, establishing the Saudi Arabian Football Federation (SAFF) has led to initiatives emphasizing player safety, including educating coaches, players, and parents about concussions.

Key Concussion Company Insights

The competitive scenario in the market is high, with key players such as NIHON KOHDEN CORPORATION, Compumedics Limited, INTEGRA LIFESCIENCES, BioDirection (NanoDx), Oculogica, Abbott, BrainScope Company Inc, BIOMÉRIEUX, Magstim, Advanced Brain Monitoring, Inc. holding significant positions. The market is notably fragmented, featuring numerous large and small companies. Key strategies employed by these market participants include adopting innovative diagnostic methods, approvals, partnerships, mergers, and geographical expansion. For instance, In January 2024, Magstim received FDA clearance for the Horizon 3.0 with StimGuide Pro, equipping physicians, nurse practitioners, clinicians, and researchers with the most advanced transcranial magnetic stimulation (TMS) technology available for treating patients diagnosed with depressive or obsessive-compulsive disorders.

Recent Developments

• In September 2024, Nihon Kohden announced that its Board of Directors had approved the acquisition of a 71.4% stake in NeuroAdvanced Corp. (NAC), the parent company of Ad-Tech Medical Instrument Corporation in the U.S. Following this transaction, both NAC and Ad-Tech will become consolidated and designated subsidiaries of Nihon Kohden, as their respective capital will account for 10% or more of Nihon Kohden’s total capital.

• In July 2024, Oculogica announced that Health Canada has granted approval for the EyeBOX concussion diagnostic device, an innovative tool aimed at aiding healthcare providers in diagnosing concussions. This regulatory approval represents a significant milestone for EyeBOX, which will now be accessible to healthcare professionals across Canada, facilitating the swift and accurate assessment of mild traumatic brain injuries (mTBIs).

• In April 2024, Abbott's i-STAT TBI cartridge received clearance from the U.S. Food and Drug Administration (FDA) for use with whole blood, enabling doctors to evaluate patients with suspected concussions right at the bedside and achieve lab-quality results in just 15 minutes. Previously, TBI assessment tests were only approved for plasma or serum, necessitating that samples be sent to a laboratory for processing and analysis.

• In December 2023, Integra LifeSciences Holdings Corporation announced that it has finalized a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a subsidiary of Johnson & Johnson MedTech, for USD 275 million in cash at closing, with customary purchase price adjustments. In addition, there is a provision for an extra USD 5 million contingent upon meeting certain regulatory milestones.
  

Concussion Market Report Scope

Global Concussion Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the concussion market report based on assessment and treatment, end use, and region.

• Assessment And Treatment Outlook (Revenue, USD Million, 2018 - 2030)

  • Treatment

  • Diagnosis

    • CT

    • MRI

    • EEG

    • Others

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Diagnostic centers

  • Neurologic clinics

  • Research centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Norway

    • Denmark

    • Sweden

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

    • Mexico

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait